Patient population Individuals were required to have histologically confirmed recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma, and had to have received at least one prior platinum-based chemotherapy regimen for management of primary disease
Patient population Individuals were required to have histologically confirmed recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma, and had to have received… Read More »Patient population Individuals were required to have histologically confirmed recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma, and had to have received at least one prior platinum-based chemotherapy regimen for management of primary disease